Clearsense, a Jacksonville, Fla.-based advanced data management and analytics technology platform serving the healthcare industry, raised $30m in financing.
The round was led by Health Catalyst Capital.
The company will use the new capital to build out its technology and advisory services.
Led by Co-founder and Chief Innovation Officer Charles Boicey, and Co-founder and Chief Executive Officer Gene Scheurer, Clearsense is a healthcare data platform-as-a-service company serving both providers and payers to provide organization stakeholders with the ability to leverage disparate data sources to lower costs, increase revenue opportunities, and improve outcomes. As an adjunctive solution, Clearsense operates within any technology landscape.
With this investment, the company will continue to innovate and develop its solutions, including the Clearsense DataHub, which will operate as the central nervous system for healthcare data, further enabling automation of data curation, preparation, normalization, and governance to streamline the ability for data to be used meaningfully and with full transparency. Clearsense will continue the expansion of advisory services, bringing industry experts in data governance, data science, research, advanced analytics, and more to operationalize data across the enterprise to ensure long-term momentous results.